Archives alta-partners

by in
Entry Author Date Location
Allakos Receives $32,000,000 Series A Funding Round 12/18/12 San Francisco
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Zafgen Obtains $21,000,000 New Funding Round 12/04/12 Boston
ZS Pharma Receives $46,000,000 Series C Funding Round 10/26/12 Texas
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Sutro Biopharma Lands $16,500,000 Series C Funding 05/08/12 San Francisco
SD Life Sciences Roundup: Illumina, Sophiris Bio, & New Funding Deals 04/05/12 San Diego
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More 01/06/12 San Diego
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring 11/22/11 San Diego
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs 10/27/11 San Francisco
Raising Funds: AnaptysBio, Sonexa, Eclipse, NextDx, Naviscan 10/18/11 San Diego
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Immune Design Rakes In Another $11M From Prior VC Round 10/05/11 Seattle
SARCode Secures $44,000,000 Series B Round 07/18/11 San Francisco
With Esperion Reboot, Lipitor Co-Discoverer Roger Newton Pushes For Therapy Beyond Drugs 05/25/11 Detroit
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Vertiflex Lands $14,000,000 Series D Financing Round 02/02/11 San Diego
Alexion Pharma Gobbles Up Taligen in $111M Buyout 01/31/11 Boston
AcelRx Prices IPO 01/21/11 San Francisco
PneumRx Raises $33M 01/04/11 San Francisco
Sutro Biopharma Grabs $36.5M in Venture Deal to Make “Biobetters” 11/17/10 San Francisco
Sutro Biopharma Secures $36,500,000 Series C Round 11/17/10 San Francisco
Ceregene Adds $11.5M 11/11/10 San Diego
Ceregene Lands $11,500,000 Series D Round 11/11/10 San Diego
ChemoCentryx, Pursuing the Dream For Autoimmune Disease, Seeks to Put a Pill in a Bottle 11/04/10 San Francisco
Life Technologies’ CEO Talks Strategy, Phenomix Falls, Arena Pharmaceuticals Grapples With FDA Setback, & More San Diego Life Sciences News 10/28/10 San Diego
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets 10/26/10 San Diego
Phenomix, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Labs Walks 10/26/10 San Diego
aTyr Pharma Obtains $23,000,000 Series C Financing 10/26/10 San Diego
Cerenis Adds $13.9M to C Round 10/21/10 Detroit
Page 2 of 4 « previous page · next page »